P S Rennie Selected Research

Therapeutics

1/2017	Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality.
1/2016	Intravesical treatment of advanced urothelial bladder cancers with oncolytic HSV-1 co-regulated by differentially expressed microRNAs.
1/2012	Fibroblast growth factor and ornithine decarboxylase 5'UTRs enable preferential expression in human prostate cancer cells and in prostate tumors of PTEN(-/-) transgenic mice.
7/2007	An HSV-1 amplicon system for prostate-specific expression of ICP4 to complement oncolytic viral replication for in vitro and in vivo treatment of prostate cancer cells.
1/2006	Targeting and killing of prostate cancer cells using lentiviral constructs containing a sequence recognized by translation factor eIF4E and a prostate-specific promoter.
1/2000	Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

P S Rennie Research Topics

Disease

10	Neoplasms (Cancer) 01/2017 - 01/2000
8	Prostatic Neoplasms (Prostate Cancer) 01/2017 - 01/2000
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2016 - 09/2008
1	Neoplasm Metastasis (Metastasis) 01/2017
1	Vesicular Stomatitis 09/2008
1	Herpes Simplex 07/2007
1	Infections 01/2006

Drug/Important Bio-Agent (IBA)

5	AndrogensIBA 01/2017 - 01/2000
3	Prostate-Specific Antigen (Semenogelase)IBA 07/2007 - 05/2000
2	Eukaryotic Initiation Factor-4EIBA 01/2012 - 01/2006
2	Peptide Initiation Factors (Initiation Factor)IBA 01/2012 - 01/2006
2	Testosterone (Sustanon)FDA Link 05/2000 - 01/2000
2	OligodeoxyribonucleotidesIBA 05/2000 - 01/2000
1	Small Interfering RNA (siRNA)IBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Neuropilin-1IBA 01/2017
1	MicroRNAs (MicroRNA)IBA 01/2016
1	5' Untranslated Regions (5' UTR)IBA 01/2012
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2012
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2012
1	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 01/2012
1	Proteins (Proteins, Gene)FDA Link 11/2009
1	human ERBB2 proteinIBA 11/2009
1	Trastuzumab (Herceptin)FDA Link 11/2009
1	AntibodiesIBA 11/2009
1	Surface Antigens (Surface Antigen)IBA 11/2009
1	LuciferasesIBA 11/2009
1	InterferonsIBA 09/2008
1	probasinIBA 07/2007
1	Peptides (Polypeptides)IBA 07/2007
1	Complement System Proteins (Complement)IBA 07/2007
1	Ganciclovir (Cytovene)FDA LinkGeneric 01/2006
1	Pharmaceutical PreparationsIBA 01/2006
1	Thymidine KinaseIBA 01/2006
1	Phosphatidylinositols (Phosphatidylinositol)IBA 06/2000
1	Insulin-Like Growth Factor I (IGF-1)IBA 06/2000
1	Insulin-Like Growth Factor Binding Protein 5IBA 06/2000
1	Insulin-Like PeptidesIBA 06/2000
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 06/2000
1	Hormones (Hormone)IBA 05/2000
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2000
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2000

Therapy/Procedure

6	Therapeutics 01/2017 - 01/2000
5	Castration 01/2017 - 01/2000
1	Prostatectomy (Retropubic Prostatectomy) 01/2017
1	Radiotherapy 01/2017
1	Immunotherapy 09/2008
1	Drug Therapy (Chemotherapy) 05/2000